# Cancer Center Support Grant

> **NIH NIH P30** · UNIVERSITY OF KANSAS MEDICAL CENTER · 2020 · $150,980

## Abstract

Overall – Project Summary
The University of Kansas Cancer Center (KUCC) is a matrix cancer center that includes: the University of
Kansas Medical Center campuses in Kansas City, Wichita and Salina, the University of Kansas in Lawrence
and via consortium agreement, the Stowers Institute for Medical Research and Children's Mercy Kansas City.
In 2015, 187 members of KUCC accounted for $13.4M of NCI funding and a total of $61.2M in overall cancer-
related funding, an increase of $10M during the previous funding period. Roy A. Jensen, MD, who is supported
by a strong, nationally recognized leadership team, leads KUCC. Over the last four years substantial progress
has been made broadening partnerships with communities throughout the KUCC catchment area, boosting
recruitment of physician-scientists, augmenting clinical research and early-phase clinical trials, advancing
education for the next generation of scientists and health care providers and heightening influence for KUCC
researchers in the national scientific community. KUCC has established four specific aims to ensure KUCC
leads in the fight against cancer:
1. Leverage unique institutional and regional assets to become a leading academic institution for transforming
 discoveries from the laboratory into new anticancer drug therapies;
2. Provide the optimal environment to focus the power of precision medicine, basic science inquiry, drug
 discovery and development, and behavioral interventions to decrease cancer incidence, morbidity and
mortality;
3. Be a nationally recognized leader in partnering with key stakeholders, community advocates and regional
 leaders to develop, promote, and foster the adoption and implementation of research-based cancer
 prevention, diagnosis, treatment, control, and survivorship practices throughout the KUCC catchment area
 to mitigate the impact of cancer; and
4. Provide leadership in envisioning, developing and implementing a thoughtful, comprehensive strategy to
 educate the next generation of physician-scientists and allied investigators in cancer research, treatment,
 prevention and control.
To accomplish these goals KUCC has four research programs: Cancer Biology, Cancer Control and Population
Health, Cancer Prevention and Survivorship, and Drug Discovery, Delivery and Experimental Therapeutics. In
addition, KUCC supports the Clinical Trials Office, five established shared resources - Biospecimen,
Biostatistics and Informatics, Clinical Pharmacology, Lead Development and Optimization and Transgenic and
Gene-Targeting – along with three developing shared resources – Cell Authentication and Pathogen
Screening, Health Communications Research and Nutrition.

## Key facts

- **NIH application ID:** 10244467
- **Project number:** 3P30CA168524-09S4
- **Recipient organization:** UNIVERSITY OF KANSAS MEDICAL CENTER
- **Principal Investigator:** ROY A. JENSEN
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $150,980
- **Award type:** 3
- **Project period:** 2012-07-11 → 2022-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10244467

## Citation

> US National Institutes of Health, RePORTER application 10244467, Cancer Center Support Grant (3P30CA168524-09S4). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10244467. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*